Hülsmann MP - Search Results

1

Metabolomics implicate eicosanoids in severe functional mitral regurgitation.

Hofbauer TM, Distelmaier K, Muqaku B, Spinka G, Seidl V, Arfsten HT, Hagn G, Meier-Menches S, Bartko PE, Pavo N, Hoke M, Prausmueller S, Heitzinger G, Pils D, Lang IM, Hengstenberg C, Hülsmann MP, Gerner C, Goliasch G. Hofbauer TM, et al. Among authors: hulsmann mp. ESC Heart Fail. 2023 Feb;10(1):311-321. doi: 10.1002/ehf2.14160. Epub 2022 Oct 10. ESC Heart Fail. 2023. PMID: 36217578 Free PMC article.

2

Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

Adlbrecht C, Kommata S, Hülsmann M, Szekeres T, Bieglmayer C, Strunk G, Karanikas G, Berger R, Mörtl D, Kletter K, Maurer G, Lang IM, Pacher R. Adlbrecht C, et al. Eur Heart J. 2008 Oct;29(19):2343-50. doi: 10.1093/eurheartj/ehn359. Epub 2008 Aug 12. Eur Heart J. 2008. PMID: 18701467

3

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

Adlbrecht C, Hülsmann M, Strunk G, Berger R, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Jakowitsch J, Maurer G, Lang IM, Pacher R. Adlbrecht C, et al. Eur J Heart Fail. 2009 Apr;11(4):361-6. doi: 10.1093/eurjhf/hfp004. Epub 2009 Feb 3. Eur J Heart Fail. 2009. PMID: 19190023 Free article.

4

Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment.

Adlbrecht C, Hülsmann M, Gwechenberger M, Strunk G, Khazen C, Wiesbauer F, Elhenicky M, Neuhold S, Binder T, Maurer G, Lang IM, Pacher R. Adlbrecht C, et al. Eur J Clin Invest. 2009 Dec;39(12):1073-81. doi: 10.1111/j.1365-2362.2009.02217.x. Epub 2009 Oct 15. Eur J Clin Invest. 2009. PMID: 19843157

5

Fractalkine is an independent predictor of mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A. Richter B, et al. Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26. Thromb Haemost. 2012. PMID: 23014777 Clinical Trial.

6

Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.

Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hülsmann M, Pacher R, Lang IM, Maurer G, Bonderman D. Mascherbauer J, et al. Circ Cardiovasc Imaging. 2013 Nov;6(6):1056-65. doi: 10.1161/CIRCIMAGING.113.000633. Epub 2013 Sep 13. Circ Cardiovasc Imaging. 2013. PMID: 24036385

7

CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure.

Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A. Koller L, et al. Atherosclerosis. 2013 Oct;230(2):414-6. doi: 10.1016/j.atherosclerosis.2013.08.008. Epub 2013 Aug 19. Atherosclerosis. 2013. PMID: 24075776

8

Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.

Koller L, Kleber ME, Brandenburg VM, Goliasch G, Richter B, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer TB, Delgado G, Tomaschitz A, Pilz S, Berger R, Mörtl D, Hülsmann M, Pacher R, März W, Niessner A. Koller L, et al. Circ Heart Fail. 2015 Nov;8(6):1059-67. doi: 10.1161/CIRCHEARTFAILURE.115.002341. Epub 2015 Aug 13. Circ Heart Fail. 2015. PMID: 26273098

9

Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.

Pavo N, Raderer M, Hülsmann M, Neuhold S, Adlbrecht C, Strunk G, Goliasch G, Gisslinger H, Steger GG, Hejna M, Köstler W, Zöchbauer-Müller S, Marosi C, Kornek G, Auerbach L, Schneider S, Parschalk B, Scheithauer W, Pirker R, Drach J, Zielinski C, Pacher R. Pavo N, et al. Heart. 2015 Dec;101(23):1874-80. doi: 10.1136/heartjnl-2015-307848. Epub 2015 Sep 28. Heart. 2015. PMID: 26416836

10

Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients.

Schrutka L, Goliasch G, Meyer B, Wurm R, Koller L, Kriechbaumer L, Heinz G, Pacher R, Lang IM, Distelmaier K, Hülsmann M. Schrutka L, et al. PLoS One. 2016 Mar 15;11(3):e0151706. doi: 10.1371/journal.pone.0151706. eCollection 2016. PLoS One. 2016. PMID: 26978526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page